FXYD3 and intrahepatic cholangiocarcinoma: In addition, western blot analysis of 10 randomly selected paired ICC tissue samples demonstrated significantly elevated FXYD3 levels in tumor tissues compared to non‐tumor tissues (Figure 2B).